news

Learning& Communication

On April 17, 2025, led by Group Vice President Chen Ye, together with Dr. Guo Chunyu, Director of the Group Research Institute, Dean Chen Ying of the Business School, and Zhao Bin, Director of the Brand Department, visited the National Center for Nanoscience and Technology for discussions and exchanges.

Introduction to Nano Research Institute

The National Center for Nanoscience and Technology (hereinafter referred to as the “National Center for Nanoscience and Technology”) is a public institution directly under the Chinese Academy of Sciences, jointly established by the Chinese Academy of Sciences and the Ministry of Education. It was approved by the Office of the Central Organization Commission in December 2003.
The National Center for Nanoscience and Technology currently has three key laboratories of the Chinese Academy of Sciences, namely the Key Laboratory of Nanobioeffects and Safety of the Chinese Academy of Sciences, the Key Laboratory of Nanostandards and Testing of the Chinese Academy of Sciences, and the Key Laboratory of Nanosystems and Multi-level Manufacturing of the Chinese Academy of Sciences.

1. Visit the Technology Exhibition Hall

Led by Dou Kaifei, deputy director of the Science and Technology Department of the National Center for Nanoscience and Technology, the group project team visited the science and technology exhibition hall of the Nano Research Institute and learned about the development history of nano technology, its application scope, clinical medicine and other aspects.

2.Exchange talks

After visiting the exhibition hall, Chen Ye, Vice President of the Group, and Guo Chunyu, Director of the Research Institute, had an in-depth exchange. At the symposium, Dr. Guo Chunyu introduced the overall development and operation of Taiai Peptide Group. Wang Lei, a researcher at the National Center for Nanoscience and Technology, shared the introduction of the “Process Bionic Extracellular Matrix Peptide Project”, and the two sides had in-depth communication and discussion on future cooperation projects.

Innovation is not only a requirement for scientific researchers, but also the expectation of every biotechnology company. In today’s increasingly fierce global scientific and technological competition, only by continuous innovation can we stay ahead. In the future, Taiai Peptide Group will take this visit and investigation as an opportunity to continuously innovate, develop, enhance scientific research capabilities, and take the road of technological innovation!